mebeverine and pentoxifylline

mebeverine has been researched along with pentoxifylline in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abd-Elsalam, SM; Bahaa, MM; El-Haggar, SM; Hegazy, SK1

Trials

1 trial(s) available for mebeverine and pentoxifylline

ArticleYear
Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 145

    Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Pain Measurement; Parasympatholytics; Pentoxifylline; Phenethylamines; Phosphodiesterase Inhibitors; Prospective Studies

2022